|
JERRY D. GARDNER, M.D.
President, Science For Organizations
|
Jerry Gardner is a physician-scientist with management and research experience at the National Institutes of Health, Saint Louis University Health Science Center and American Home Products. He has trained more than 100 biomedical investigators.
His experience spans new pharmaceutical product development, directing NIH research programs, biomedical science and the federal government (including FDA), and managing large biomedical research programs.
Dr. Gardner has published more than 300 scientific papers in a variety of medical and scientific journals. These have included studies on:
|
Gastrointestinal peptides and cancer (Trends Endocrinol Metab) |
|
Assessing the action of proton pump inhibitors using integrated acidity (Aliment Pharmacol & Ther) |
|
Antibodies to reverse toxic drug effects (Pharmacol Rev) |
|
Treatment of pancreatic cholera with streptozotocin (New Eng J Med) |
|
Zollinger Ellison syndrome (J Clin Invest; Gastroenterol: Ann Int Med) |
|
Development of a bombesin receptor antagonist (Nature) |
|
Incidence and etiology of Cushing’s syndrome (New Eng J Med) |
|
Discovery of a cholecystokinin receptor antagonist (J Biol Chem) |
|
Localization of islet cell tumors by dynamic CT scanning (Gastroenterol; Am J Radiol) |
|
Reduced peptide bond analogues of Substance P (J Biol Chem) |
|
Different states of the cholecystokinin receptor (Proc Natl Acad Sci) |
Known internationally as a leading scientific researcher, Dr. Gardner belongs to a number of scientific organizations, serves on editorial boards of many leading scientific journals, and has edited major textbooks. He has served on advisory boards at academic medical centers, including Harvard, Johns Hopkins, UCLA and the University of Pennsylvania, and on the nominating committee for the Nobel Prize in medicine and physiology.
Dr. Gardner graduated from medical school at the University of Pennsylvania where he also did his clinical training. He received his research training at the National Institutes of Health
|
|
|
|
Watch the YouTube video of the presentation by Dr. Gardner entitled "The Cause of GERD" to the Division of Gastroenterology & Hepatology, Stanford University Medical Center, June 15, 2016.
The Cause of GERD
|
|
|
ARISHEL, INC.
14621 Settlers Landing Way
North Potomac, MD 20878
Phone: 301-424-2806
Fax: 301-424-8563
Web: http://www.arishel.com
Arishel is headed by Harold Boxenbaum, Ph.D., who serves on the editorial boards of two scientific journals and holds an adjunct professorship at Georgetown University Medical School. Arishel offers pharmacokinetics, toxicokinetics, and clinical pharmacology services to the pharmaceutical, medical, biotechnology, and nutraceutical fields.
Arishel's other services include protocol preparation and review, data analysis, report writing, legal consultation, and oral presentations. Arishel also provides on-site pharmacokinetics training and continuing education services.
|
|
|
GARVEY ASSOCIATES, INC.
10215 Gary Road
Potomac, MD 20854
Phone: 301-299-3431
Fax: 301- 299-5931
Web: http://www.garveyassociates.com
Garvey Associates, Inc. (GAI), founded by Thomas Q. Garvey III, M.D., is a medical/scientific consulting firm that has worked with pharmaceutical, medical device, and biologics firms worldwide for nearly 25 years. The firm designs clinical trials and programs of clinical trials for prescription and over-the-counter drugs and devices. GAI also analyzes, organizes, and presents data derived from clinical trials and composes New Drug Applications. GAI has had a great deal of experience with a variety of practical and theoretical problems related to all aspects of drug development, including data analysis and interpretation and submissions to and interactions with FDA.
|
|
|
IRVING CONSULTING GROUP
P.O. Box 258
Pluckemin, NJ 07978
Phone: 908-725-5992
Fax: 908-725-6947
Web: http://www.irvingconsulting.com
Irving Consulting Group (ICG) is led by Irving K. Hwang, Ph.D., a statistical consultant with more than 30 years' experience in global new drug development. Dr. Hwang has served in major pharmaceutical and biotech companies to design and analyze results from clinical trials for the development of new drugs and vaccines. And he has worked on 35 successful New Drug Applications and European Union registrations. ICG's biostatistical consulting services include clinical program development, protocol design, data analysis, statistical trouble-shooting, and report/dossier preparation/review for regulatory submission.
|
|
|
3D COMMUNICATIONS
5208 Wissioming Road
Bethesda, MD 20816
Phone : 301-320-9331
Fax: 301-229-4345
Web: http://www.3dcommunications.us
3D Communications is a strategic communications training and production firm headed by award-winning journalists and producers, James DiBiasi, Cindy DiBiasi, and Penny Daniels. They specialize in serving healthcare industry clients who face today's high-stakes communications challenges. And they provide expertise in messaging, presentation writing and coaching, media training, marketing and business strategy. Whether helping a major pharmaceutical firm prepare for an FDA hearing or coaching executives to meet the media, 3D Communications professionals work with clients to define their need and craft targeted messages, presentations, and productions to deliver winning results.
|
|
|
AccelaPHARM
245 8th Avenue, No. 385
New York, NY 10011
Phone : 917-733-5311
Web: http://www.accelapharm.com
AccelaPHARM is headquartered in New York City with offices in Jerusalem, Israel; Cambridge, United Kingdom; and Melbourne Australia. We are a staff of seasoned pharmaceuticals executives with PHD's, MD's, Pharm D's and MBA's that have filed over 30 INDs and have led or participated in the approval of over 9 NDAs. Our group has dealt with regulatory authorities in over 20 countries, including the FDA, PMDA, MHRA, and EMEA.
AccelaPHARM assists both pharmaceutical and biotechnology companies in accelerating the development of their new molecular entitites and financial institutions in understanding the probability of technical and regulatory success to better predict the potential risks and rewards in investing in new drug development programs.
|
|
|
SCIFOR, INC.
301 Fields Lane
Brewster, NY 10509
Phone: 800-446-4966
Fax: 845-277-2339
Web: http://www.scifor.com
SciFor offers high quality poster production services for the scientific community. Specialists in printing, graphic design, and technology, SciFor also delivers scientific communications in other formats, ranging from bound volumes of miniature posters and handouts to CD-ROMs. SciFor's research library maintains a vast archive of posters and white papers. The poster research library is completely free, unrestricted, and international in scope.
|
|
|